Drugs and brands

Orforglipron

Every GLP-1 the FDA has approved, and the active ingredient inside each one.

What is Orforglipron?

The generic name for Foundayo, and the first non-peptide GLP-1 agonist to reach approval.

Like tirzepatide, it carries an oral-contraceptive warning, because slower stomach emptying can change how well a pill is absorbed. Anyone relying on the contraceptive pill should use a non-oral option, or back it up with a barrier method, for 30 days from the first dose and from every dose step-up.

Related reading: Foundayo (Orforglipron): the GLP-1 Pill With No Fasting Rule

GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature.

Where Orforglipron comes up on this site

On GLP Watchdog, Orforglipron comes up in 12 research articles, 21 seller reviews and 2 tools.

Other terms under Drugs and brands

Where the evidence lives